| P50 | author | Sue Leurgans | Q60697378 |
| | Steven E. Arnold | Q64157128 |
| | David A Bennett | Q66739430 |
| | Julie A. Schneider | Q67212579 |
| | Zoe Arvanitakis | Q96585161 |
| | Ana W Capuano | Q104617620 |
| | Lisa L. Barnes | Q124829307 |
| P2093 | author name string | Rexford S Ahima | |
| | Jeremy J Pruzin | |
| P2860 | cites work | Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology | Q40059968 |
| | Cardiovascular Outcomes of Patients in SAVOR-TIMI 53 by Baseline Hemoglobin A1c. | Q40366726 |
| | Diabetes and cardiovascular disease. The Framingham study | Q41509493 |
| | Type 2 diabetes mellitus and biomarkers of neurodegeneration | Q41531923 |
| | Elevated HbA1c is associated with increased risk of incident dementia in primary care patients | Q41668805 |
| | Advanced glycation end products are mitogenic signals and trigger cell cycle reentry of neurons in Alzheimer's disease brain | Q41757331 |
| | Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study | Q42925710 |
| | Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study | Q42925712 |
| | Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes. | Q42950655 |
| | Hyperglycaemia promotes cerebral barrier dysfunction through activation of protein kinase C-β. | Q43407851 |
| | Glucose tolerance status and risk of dementia in the community: the Hisayama study | Q43584777 |
| | Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study | Q43935519 |
| | Increased risk of type 2 diabetes in Alzheimer disease | Q44745172 |
| | Brain accumulation of amyloid β protein visualized by positron emission tomography and BF-227 in Alzheimer's disease patients with or without diabetes mellitus | Q46530266 |
| | Beta-amyloid deposition in brains of subjects with diabetes | Q46697376 |
| | Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. | Q47408299 |
| | Diabetes is related to cerebral infarction but not to AD pathology in older persons | Q48342090 |
| | Silent brain infarcts and the risk of dementia and cognitive decline | Q48353038 |
| | Cortical thinning in type 2 diabetes mellitus and recovering effects of insulin therapy | Q48441388 |
| | The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease. | Q51011184 |
| | Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects. A retrospective postmortem immunocytochemical and histofluorescent study. | Q53220314 |
| | Diabetes mellitus and the risk of dementia: The Rotterdam Study. | Q53231897 |
| | Diabetes and the risk of stroke. The Honolulu Heart Program | Q69730010 |
| | Stroke patterns, etiology, and prognosis in patients with diabetes mellitus | Q80070073 |
| | Complex mechanisms linking neurocognitive dysfunction to insulin resistance and other metabolic dysfunction | Q26745936 |
| | Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain | Q27003253 |
| | The anti-diabetic drug metformin reduces BACE1 protein level by interfering with the MID1 complex | Q27319458 |
| | Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers | Q28308082 |
| | The Minority Aging Research Study: ongoing efforts to obtain brain donation in African Americans without dementia | Q28728646 |
| | Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 | Q30358426 |
| | Human cerebral neuropathology of Type 2 diabetes mellitus | Q33710643 |
| | Diabetes and cognitive systems in older black and white persons | Q33721775 |
| | Increased Alzheimer's disease neuropathology is associated with type 2 diabetes and ApoE ε.4 carrier status | Q33927061 |
| | Insulin resistance and hippocampal volume in women at risk for Alzheimer's disease | Q33940256 |
| | Aggregation of vascular risk factors and risk of incident Alzheimer disease | Q33989502 |
| | Altered expression of diabetes-related genes in Alzheimer's disease brains: the Hisayama study | Q34027810 |
| | Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants | Q34164504 |
| | Microinfarct pathology, dementia, and cognitive systems | Q34590151 |
| | Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer's disease and tauopathies | Q35006687 |
| | Type 2 diabetes is negatively associated with Alzheimer's disease neuropathology | Q35184690 |
| | Does diabetes protect or provoke Alzheimer's disease? Insights into the pathobiology and future treatment of Alzheimer's disease | Q35618911 |
| | Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases | Q35753534 |
| | Modeling the Role of the Glymphatic Pathway and Cerebral Blood Vessel Properties in Alzheimer's Disease Pathogenesis | Q35800921 |
| | Hyperglycemia modulates extracellular amyloid-β concentrations and neuronal activity in vivo | Q35836136 |
| | Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline | Q35858095 |
| | Overview and findings from the religious orders study | Q36130996 |
| | Overview and findings from the rush Memory and Aging Project | Q36226167 |
| | Different patterns of cerebral injury in dementia with or without diabetes | Q37397970 |
| | Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore Longitudinal Study of Aging | Q37603091 |
| | Type 2 diabetes as a risk factor for Alzheimer's disease: the confounders, interactions, and neuropathology associated with this relationship | Q38073603 |
| | (2) Classification and diagnosis of diabetes | Q38299539 |
| | Relation of cerebral vessel disease to Alzheimer's disease dementia and cognitive function in elderly people: a cross-sectional study | Q38391179 |
| | Diabetes and function in different cognitive systems in older individuals without dementia | Q38408860 |
| | Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function | Q38422040 |
| | Relation of cerebral infarctions to dementia and cognitive function in older persons | Q38428811 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 41-47 | |
| P577 | publication date | 2016-10-17 | |
| P1433 | published in | Alzheimer Disease and Associated Disorders | Q4738827 |
| P1476 | title | Diabetes, Hemoglobin A1C, and Regional Alzheimer Disease and Infarct Pathology | |
| P478 | volume | 31 | |